Class / Patent application number | Description | Number of patent applications / Date published |
514300300 | Fungus (e.g., athlete's foot, ringworm, etc.) destroying or inhibiting | 71 |
20110015120 | Pharmaceutical and cosmetic compositions including lactoferrin, ciclopirox, etidronic acid - Pharmaceutical and cosmetic compositions for topical use comprising Lactoferrin, Ciclopirox and/or salts thereof, Etidronic Acid and/or salts thereof and use of said compositions in the treatment of dermatological disorders and conditions such as seborrheic dermatitis and dandruff. | 01-20-2011 |
20110144004 | RICIN-LIKE TOXIN VARIANTS FOR TREATMENT OF CANCER, VIRAL OR PARASITIC INFECTIONS - The present invention provides a protein having an A chain of a ricin-like toxin, a B chain of a ricin-like toxin and a heterologous linker amino acid sequence, linking the A and B chains. The linker sequence contains a cleavage recognition site for a disease specific protease such as a cancer, fungal, viral or parasitic protease. The invention also relates to a nucleic acid molecule encoding the protein and to expression vectors incorporating the nucleic acid molecule. Also provided is a method of inhibiting or destroying mammalian cancer cells, cells infected with a virus, a fungus, or parasite, or parasites utilizing the nucleic acid molecules and proteins of the invention and pharmaceutical compositions for treating human cancer, viral infection, fungal infection, or parasitic infection. | 06-16-2011 |
20110172145 | ANTIMICROBIAL COMPOUNDS - The present invention relates to a compound of formula (I) AA-AA-AA-X—Y—Z wherein, in any order, 2 of said AA (amino acid) moieties are cationic amino acids and 1 of said AA is an amino acid with a lipophilic R group, the R group having 14-27 non-hydrogen atoms; X is a N atom, which may be substituted by a branched or unbranched C | 07-14-2011 |
20110224131 | ANTIFUNGAL PAINTS AND COATINGS - Antifungal and antibacterial peptides, polypeptides and proteins as antifungal additives for paint and other coatings are disclosed, along with antifungal compostions, and coated surfaces with antifungal properties. Methods of using the coatings for treating and/or inhibiting growth of mold, mildew and other fungi and bacteria on objects such as building materials that are susceptible to such infestation are also disclosed. | 09-15-2011 |
20110269672 | ANTIFUNGAL PAINTS AND COATINGS - Antifungal and antibacterial peptides, polypeptides and proteins as antifungal additives for paint and other coatings are disclosed, along with antifungal compositions, and coated surfaces with antifungal properties. Methods of using the coatings for treating and/or inhibiting growth of mold, mildew and other fungi and bacteria on objects such as building materials that are susceptible to such infestation are also disclosed. | 11-03-2011 |
20110312877 | ENGINEERED TUNABLE NANOPARTICLES FOR DELIVERY OF THERAPEUTICS, DIAGNOSTICS, AND EXPERIMENTAL COMPOUNDS AND RELATED COMPOSITIONS FOR THERAPEUTIC USE - Biomedical nanoparticles are disclosed based on new engineered modular carrier macromolecules, on engineered macromolecules or associated entities providing an internal nanoparticle structure, and compositions for minimizing non-specific binding of the nanoparticles while enabling efficient and convenient targeting to cells and tissues. These nanoparticles may be used to deliver atomic or molecular or associated entities which are useful for diagnostics, primarily in vivo imaging, for therapeutics, for vaccines, or for experimental research. Nanoparticles comprising combinations of active entities such as gene inhibitors with gene expression cassettes or imaging agents with therapeutic agents, and polyamide compounds useful for treatment of microbial infections are also disclosed. | 12-22-2011 |
20110319320 | ANTIFUNGAL PAINTS AND COATINGS - Antifungal and antibacterial peptides, polypeptides and proteins as antifungal additives for paint and other coatings are disclosed, along with antifungal compostions, and coated surfaces with antifungal properties. Methods of using the coatings for treating and/or inhibiting growth of mold, mildew and other fungi and bacteria on objects such as building materials that are susceptible to such infestation are also disclosed. | 12-29-2011 |
20120010128 | ANTIFUNGAL PAINTS AND COATINGS - Antifungal and antibacterial peptides, polypeptides and proteins as antifungal additives for paint and other coatings are disclosed, along with antifungal compostions, and coated surfaces with antifungal properties. Methods of using the coatings for treating and/or inhibiting growth of mold, mildew and other fungi and bacteria on objects such as building materials that are susceptible to such infestation are also disclosed. | 01-12-2012 |
20120010129 | ANTIFUNGAL PAINTS AND COATINGS - Antifungal and antibacterial peptides, polypeptides and proteins as antifungal additives for paint and other coatings are disclosed, along with antifungal compostions, and coated surfaces with antifungal properties. Methods of using the coatings for treating and/or inhibiting growth of mold, mildew and other fungi and bacteria on objects such as building materials that are susceptible to such infestation are also disclosed. | 01-12-2012 |
20120028884 | ANTIFUNGAL PAINTS AND COATINGS - Antifungal and antibacterial peptides, polypeptides and proteins as antifungal additives for paint and other coatings are disclosed, along with antifungal compostions, and coated surfaces with antifungal properties. Methods of using the coatings for treating and/or inhibiting growth of mold, mildew and other fungi and bacteria on objects such as building materials that are susceptible to such infestation are also disclosed. | 02-02-2012 |
20120028885 | ANTIFUNGAL PAINTS AND COATINGS - Antifungal and antibacterial peptides, polypeptides and proteins as antifungal additives for paint and other coatings are disclosed, along with antifungal compositions, and coated surfaces with antifungal properties. Methods of using the coatings for treating and/or inhibiting growth of mold, mildew and other fungi and bacteria on objects such as building materials that are susceptible to such infestation are also disclosed. | 02-02-2012 |
20120028886 | ANTIFUNGAL PAINTS AND COATINGS - Antifungal and antibacterial peptides, polypeptides and proteins as antifungal additives for paint and other coatings are disclosed, along with antifungal compostions, and coated surfaces with antifungal properties. Methods of using the coatings for treating and/or inhibiting growth of mold, mildew and other fungi and bacteria on objects such as building materials that are susceptible to such infestation are also disclosed. | 02-02-2012 |
20120065126 | Pharmaceutical Compositions Containing Antifungal Peptides - The invention relates to a pharmaceutical composition containing, in a pharmaceutical carrier, a peptide comprising at least one sequence motif of the following general formula (I) Hel1-HB-Hel2. The invention also relates to the use and production of said pharmaceutical compositions. | 03-15-2012 |
20120088717 | METHOD FOR TREATING FUNGAL INFECTION WITH ANTIFUNGAL BIFUNCTIONAL MOLECULES - The present invention is directed to a method of treating a fungal infection with a fusion peptide that includes a fungal targeting agent and a channel-forming domain consisting essentially of amino acids 451-626 of colicin Ia. The fungal targeting agent can be a pheromone, such as an alpha-mating pheromone. The fusion peptides of the peptides of the present invention are particularly useful for the treatment of fungal infections in a wide variety of organisms. The fusion peptides can be prepared from the nucleic acids, such as when a vector having the nucleic acid is included in a host cell. | 04-12-2012 |
20120165247 | USE OF A COMPOSITION FOR TREATMENT AND/OR PROPHYLAXIS OF PLANTS AND RELATIVE COMPOSITION - A method of using a beef extract or a protein hydrolisate or a mixture of beef extract and protein hydrolisate, as active substance, for treatment and/or prophylaxis of plants against the action of pathogens is described. A composition including a beef extract or a protein hydrolisate or a mixture of beef extract and protein hydrolisate, as active substance, for treatment and/or prophylaxis of plants against the action of pathogens is also described. | 06-28-2012 |
20120295840 | TREATMENT OF ASPERGILLUS INFECTIONS WITH ALPHA THYMOSIN PEPTIDES - A method for treating a human infected with | 11-22-2012 |
20130023461 | OLIGOPEPTIDE COMPOUNDS AND USES THEREOF - The present invention relates to novel agents, pharmaceutical compositions containing them, and their use in therapy, particularly anti-microbial and anti-cancer therapy. In particular, the present invention relates to novel peptide-based compounds based on SEQ ID NO:40 which have surprisingly been shown to have inhibitory effects on the growth and/or viability of cells, particularly bacterial and cancer cells. Also provided are therapeutic and non-therapeutic methods which comprise the use of peptides of the invention. | 01-24-2013 |
20130267459 | Anti-Pathogen Systems - Provided is a system for protecting plants from attack by pests, including pathogens such as fungi. Specifically, a plant defensin is provided in conjunction with a protease inhibitor protects a plant from pest attack or reduces severity of an attack. | 10-10-2013 |
20130331311 | Synergistic Combinations of Polyene Fungicides and Non-Ribosomal Peptides and Related Methods of Use - The present invention includes compositions comprising a synergistic fungicidal combination of a polyene fungicide and at least one lipopeptide and methods for using such compositions in controlling fungal pathogens. | 12-12-2013 |
20140128315 | CASPOFUNGIN OR SALTS THEREOF WITH HIGH PURITY, AS WELL AS PREPARATION METHOD AND USE THEREOF - Disclosed are a high purity of caspofungin or salts thereof, and a preparation method thereof, and use thereof. Disclosed are a caspofungin or salts thereof with low solvent residue and hyposaline, and a preparation process comprising: dissolving a crude product of caspofungin or slats thereof into a system of water and acetic acid, them mixing with a first organic solvent ethyl alcohol, subsequently mixing with a second organic solvent ethyl acetate, then being subject to filtration and drying together with water, to obtain caspofungin or salts thereof with high stability, low solvent residue and hyposaline. | 05-08-2014 |
20140155321 | Polypeptides and Their Use - The present invention relates to a polypeptide or a product comprising said polypeptide for use in the treatment and/or prevention of a fungal infection caused by | 06-05-2014 |
20140296135 | MEDICAMENT FOR THE TREATMENT OF FUNGAL INFECTIONS PARTICULARLY ASPERGILLOSIS - The combination of pentraxin PTX3 with antifungals is described for the treatment of fungal infections and particularly for infections caused by | 10-02-2014 |
20150289529 | USE OF A COMPOSITION COMPRISING AN ANTIMICROBIAL PEPTIDE AS A FOOD PRESERVATIVE - The inventors provide the use of a composition comprising an antimicrobial polypeptide comprising Blad or an active variant thereof to prevent or inhibit spoilage of a foodstuff by a microorganism. Also provided is a method of preventing or inhibiting spoilage of a foodstuff by a microorganism comprising administering to a foodstuff in need thereof an effective amount of a composition comprising an antimicrobial polypeptide comprising Blad or an active variant thereof. | 10-15-2015 |
20150366890 | COMPOSITIONS AND METHODS FOR TREATING FUNGAL INFECTIONS - The methods and compositions described herein relate to the treatment of fungal infections, e.g. by potentiating the sensitivity of fungi to anti-fungal agents. | 12-24-2015 |
20150366948 | FUNGAL IRON ACQUISITION INHIBITORS AND USES THEREOF - A method of treating a fungal infection in a subject includes topically administering to the subject a therapeutically effective amount of a fungal iron acquisition inhibitor to treat fungal infection in the subject. | 12-24-2015 |
20160129078 | Rhomboid Proteins and Uses Thereof - Compositions and methods for managing the growth, life cycle, functionality, or biological progression of cells, tissues, and organisms by introducing rhomboid proteins or peptides into the internal and external environment of the cells, tissues, and organisms. In particular, embodiments comprise compositions and methods for overcoming drug resistance in disease, and for sensitizing cells, tissues, and organisms to agents to treat disease, and methods for producing such compositions. The compositions and methods include rhomboid proteins, polypeptides, and/or peptides, and nucleic acids encoding such proteins, polypeptides, and/or and peptides, corresponding to the | 05-12-2016 |
20190142010 | PESTICIDAL COMPOSITIONS | 05-16-2019 |
514300400 | Candida (e.g., Candida albicans, etc.) | 18 |
20110071072 | Antifungal Bone Cements - Antifungal bone cement compositions and methods of using the same are disclosed. In one aspect, a bone cement composition comprises an echinocandin lipopeptide antifungal agent and a cementing agent. Optionally, the echinocandin lipopeptide antifungal agent is selected from the group consisting of micafungin, caspofungin and anidulafungin. The echinocandin lipopeptide antifungal agent is optionally micafungin. Methods of preventing a fungal infection following an arthroplasty procedure are also provided. | 03-24-2011 |
20110183891 | Methods and Compositions for Inhibiting Fungal Infection and Disease - The present invention describes a previously unknown interaction between secreted aspartic proteases (SAPs), including SAPs 4-6 of | 07-28-2011 |
20110195894 | CD5 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INFECTIOUS AND INFLAMMATORY PROCESSES OF FUNGAL ORIGIN - The present invention refers to pharmaceutical compositions comprising the soluble CD5 ectodomain and its use for the prevention and/or treatment of fungal infections and/or fungal sepsis, as well as inflammatory disorders of fungal origin. | 08-11-2011 |
20110230396 | ANTI-INFECTIVE COMPOUNDS AND USES THEREOF - A medicament to prevent or cure fungal infections of the skin or body openings in an immunologically compromised person or animal can comprise Cystatin S, Cystatin SA, Cystatin SN, or similar agents. | 09-22-2011 |
20110269673 | Antimicrobial Peptides - The present invention relates to peptides comprising amino acids according to Formula I | 11-03-2011 |
20110281788 | ANTI FUNGAL THERAPY - The present invention relates to the treatment of fungal infections and provides compounds, compositions, methods and for treating the same. | 11-17-2011 |
20120101030 | Caspofungin Composition - The present invention relates to a composition comprising caspofungin or a pharmaceutical acceptable salt thereof and succinate or lactate as a buffering agent. | 04-26-2012 |
20120190613 | ECHINOCANDIN DERIVATIVES - The invention features echinocandin class compounds that have been modified to (i) have activity against one or more fungal species or genera; (ii) have increased aqueous solubility; (iii) have an increased therapeutic index; (iv) be suitable for topical administration; and/or (v) be suitable for oral administration. The echinocandin class compounds of the invention include, for example, a PEG, alkyl-PEG, aryl-PEG, alkaryl-PEG, PEG-alkyl, PEG-aryl, or PEG-alkaryl substituent. | 07-26-2012 |
20120258907 | TREATMENT OF FUNGAL AND/OR PROTIST INFECTIONS - The present invention relates to the use of a polypeptides, comprising repeats of a peptide derived from a Heparan Sulphate Proteoglycan (HSPG) receptor binding region of an apolipoprotein, for treating or preventing a fungal and/or protist infection. The invention further relates to the use of such peptides for treating or preventing the contamination of surfaces or objects with such peptides. | 10-11-2012 |
20120302494 | SYNERGISTIC COMBINATIONS OF POLYENE FUNGICIDES AND NON-RIBOSOMAL PEPTIDES AND RELATED METHODS OF USE - The present invention includes compositions comprising a synergistic fungicidal combination of a polyene fungicide and at least one lipopeptide and methods for using such compositions in controlling fungal pathogens. | 11-29-2012 |
20150024997 | ANTIFUNGAL AGENTS AND USES THEREOF - The invention features echinocandin class compounds. The compounds can be useful for the treatment of fungal infections. | 01-22-2015 |
20150072923 | Caspofungin Composition - The present invention relates to a composition comprising caspofungin or a pharmaceutical acceptable salt thereof and succinate or lactate as a buffering agent. | 03-12-2015 |
20160008423 | Occidiofungin, a unique antifungal glycopeptide produced by a strain of Burkholderia contaminans | 01-14-2016 |
20160039873 | PEPTIDES WITH ANTIFUNGAL ACTIVITY AND METHODS OF USING THE PEPTIDES - Compositions with antifungal activity and methods of using such compositions are provided herein. In particular the compositions are peptides of SEQ ID NO: 1 and variations thereof. The peptides may contain L or D amino acids and may be circularized, dimerized or otherwise modified to make the compositions resistant to proteolysis. The compositions may be used to inhibit microbial growth and in particular fungal growth. | 02-11-2016 |
20160075740 | ANTIFUNGAL AGENTS AND USES THEREOF - The invention features echinocandin class compounds. The compounds can be useful for the treatment of fungal infections. | 03-17-2016 |
20160106807 | Method of Treatment - The present disclosure relates to the control of fungal infection of horn-like envelopes covering dorsal and terminal phalanges in humans and animals and related cerebral protrusions in animals as well as keratin comprising material on surfaces of humans and animals. Agents and natural and synthetic formulations and extracts useful for the control of fungal infection of these envelopes and related protrusions and keratin comprising material are also encompassed by the subject disclosure. In an embodiment, the present disclosure teaches the treatment of fungal infection of nails and in particular onychomycosis in humans. | 04-21-2016 |
20160137617 | NEW MACROCYCLIC AMIDINOUREA DERIVATIVES, METHODS OF PREPARATION AND USES THEREOF AS CHITINASE INHIBITORS - The present invention relates to macrocyclic amidinourea derivatives of formula 8, methods of preparation and uses thereof, pharmaceutical compositions in particular to be used as chitinase inhibitors in the treatment of a fungal infection. | 05-19-2016 |
20170232004 | METHODS FOR TREATING FUNGAL INFECTIONS | 08-17-2017 |
514300500 | Yeast | 1 |
20160102052 | Use of Cysteamine in Treating Infections caused by Yeasts/Moulds - The present invention relates to compositions comprising cysteamine or a derivative thereof for use in treating infections caused by yeasts or moulds. | 04-14-2016 |
514300600 | Cyclopeptide utilizing | 25 |
20110015121 | CYCLIC COMPOUND AND SALT THEREOF - A compound useful as an antifungal agent, particularly a therapeutic agent for deep-seated mycoses, is provided. A fungus | 01-20-2011 |
20110105387 | Method of treatment with rapamycin - The invention comprises a method of treatment using an oral capsule dose of rapamycin formulated with PEG-lipids. Two types of PEG-lipids are used in the formulation. A solubilizing agent dissolves the rapamycin, and solidifying agent is used to convert the solution of rapamycin/solubilizing agent to a more solid form. | 05-05-2011 |
20110136729 | Occidiofungin, a unique antifungal glycopeptide produced by a strain of burkholderia contaminans - The present invention is directed to novel antifungal glycopeptide compounds and salts thereof produced by a strain of | 06-09-2011 |
20120231996 | Phalloidin derivatives and methods for their synthesis - The invention provides a cyclomonomer having actin-binding activity. The cyclomonomer is of utility for the study of the molecular biology of actin polymerization. The cyclomonomer is also useful for the study of and treatment of the toxic effects of | 09-13-2012 |
20130023462 | LYOPHILIZED ANTI-FUNGAL COMPOSITIONS - A lyophilized anti-fungal composition comprises (A) caspofungin, or a pharmaceutically acceptable salt thereof, in an effective amount; (B) one or more non-reducing sugars having a glass transition temperature T | 01-24-2013 |
20130090284 | ISOLATION, IDENTIFICATION, AND USES OF ANTIFUNGAL COMPOUNDS - In one aspect, the invention relates to isolated compounds useful as antifungal agents, for example, compounds having a structure represented by a formula: | 04-11-2013 |
20130096053 | POSACONAZOLE INTRAVENOUS SOLUTION FORMULATIONS STABILIZED BY SUBSTITUTED BETA-CYCLODEXTRIN - The present invention relates to aqueous solutions useful as pharmaceutical compositions of posaconazole for intravenous administration. These compositions include a solubilizing agent, such as a modified β-cyclodextrin in an acidified solution, which can also include a chelating agent such as disodium edetate (EDTA). In clinical trials, a 200 mg posaconazole dose of the selected composition was found to achieve acceptable pharmacokinetic properties. | 04-18-2013 |
20130225482 | CASPOFUNGIN ANALOG, AND PREPARATION METHOD AND USES THEREOF - Disclosed are a caspofungin analog, and a preparation method and applications thereof. The caspofungin analog has a structure as represented in Formula 3. | 08-29-2013 |
20130244930 | ANTIFUNGAL AGENTS AND USES THEREOF - The invention features echinocandin class compounds. The compounds can be useful for the treatment of fungal infections. | 09-19-2013 |
20130288956 | COMBINED PHARMACEUTICAL COMPOSITION AS ANTIFUNGAL AGENT - An object of the present invention is to provide a pharmaceutical composition having superior antifungal activity. The present invention provides a pharmaceutical composition comprising 3-(3-(4-(pyridin-2-yloxymethyl)-benzyl)-isoxazol-5-yl)-pyridin-2-ylamine or 2-amino-1-((phosphonooxy)methyl)-3-(3-((4-((2-pyridinyloxy)methyl)phenyl)methyl)-5-isoxazolyl)-pyridinium or a salt thereof in combination with an antifungal agent. | 10-31-2013 |
20130296229 | CASPOFUNGIN ANALOG AND APPLICATIONS THEREOF - Disclosed are a caspofungin analog and applications thereof. Said caspofungin analog is a compound having a structure as indicated in Formula (4), or pharmaceutically acceptable slats thereof. R1 can be chosen from hydroxyl, benzyloxy, phenoxy, substituted phenoxy, or substituted benzyloxy. R | 11-07-2013 |
20130331312 | MEDICINAL COMPOSITION CONTAINING ECHINOCANDIN ANTIFUNGAL AGENT MICAFUNGIN AND PREPARATION METHOD AND USE THEREOF - The present invention provides a medicinal composition containing micafungin or a pharmaceutically acceptable salt thereof and trehalose as a stabilizing agent. | 12-12-2013 |
20130338060 | LIQUID MEDICINAL COMPOSITION CONTAINING ECHINOCANDIN ANTIFUNGAL AGENT MICAFUNGIN - The present invention provides a liquid medicinal composition containing micafungin or a pharmaceutically acceptable salt thereof and a stabilizing agent. | 12-19-2013 |
20140024578 | AUREOBASIDIN DERIVATIVES AND METHODS OF SYNTHESIS - In general, the invention relates to methods of synthesizing AbA derivatives that are useful for treating infection and amenable to further chemical elaboration. These novel methods are scalable for industrial production and employ safer, simpler, and more efficient process conditions. Furthermore, the invention also provides novel compounds and intermediates useful for implementing the methods described herein and/or for the treatment of infection. | 01-23-2014 |
20140142032 | Caspofungin Acetate Formulations - A caspofungin composition includes caspofungin acetate and at least one amino acid, where the composition is a solid. The solid composition may be made by forming a liquid mixture including a solvent, caspofungin acetate and the amino acid(s), and lyophilizing the liquid mixture. | 05-22-2014 |
20140221274 | LOW IMPURITY CONTENT CASPOFUNGIN PREPARATION, METHOD FOR PREPARING SAME, AND USE THEREOF - Disclosed is a low impurity content caspofungin pharmaceutical composition, also disclosed is a method for preparing the low impurity content caspofungin pharmaceutical composition. The caspofungin pharmaceutical composition provided in the present invention is provided with great stability. | 08-07-2014 |
20140274882 | METHODS, COMPOSITIONS, AND KITS FOR DETECTION OF ASPERGILLOSIS - Provided herein are methods for detecting an | 09-18-2014 |
20140329741 | USE OF CYCLIC PEPTIDES FROM FLAXSEED FOR IMPROVING ANIMAL AND HUMAN HEALTH - The present application includes a method for improving human and animal health comprising administering an effective amount of a linus cyclopeptide (LCP) extract from flaxseed to a subject in need thereof. Also included are feeds, foodstuffs, functional food compositions, natural product compositions nutraceuticals and food additive compositions comprising an LCP extract from flaxseed. | 11-06-2014 |
20150018270 | ISOLATION, IDENTIFICATION, AND USES OF ANTIFUNGAL COMPOUNDS - In one aspect, the invention relates to isolated compounds useful as antifungal agents, for example, compounds having a structure represented by a formula: | 01-15-2015 |
20150024998 | ISOLATION, IDENTIFICATION, AND USES OF ANTIFUNGAL COMPOUNDS - In one aspect, the invention relates to isolated compounds useful as antifungal agents, for example, compounds having a structure represented by a formula: wherein R | 01-22-2015 |
20150045290 | Bacillus Sp. Biosurfactants, Composition Including Same, Method for Obtaining Same, and Use Thereof - Biosurfactants produced by a strain of | 02-12-2015 |
20150065417 | HIGH PURITY CYCLOPEPTIDE COMPOUND AS WELL AS PREPARATION METHOD AND USE THEREOF - Disclosed is a high purity cyclopeptide compound, the chemical structure of which is represented by formula (I). R represents H or a cation capable of forming a pharmaceutically acceptable salt, the purity being greater than or equal to 99.0%. Further disclosed are preparation method and use of the high purity cyclopeptide compound. | 03-05-2015 |
20150087583 | DOSING REGIMENS FOR ECHINOCANDIN CLASS COMPOUNDS - The invention features pharmaceutical compositions, methods, and kits featuring dosing gimens and oral dosage formulations for administration of echinocandin class compounds. | 03-26-2015 |
20150126436 | METHOD OF TREATING SCEDOSPORIUM SPP. INFECTION - The present invention provides a method of treatment of | 05-07-2015 |
20160008274 | TREATMENT OF NAIL DISORDERS | 01-14-2016 |